Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy.

Int J Environ Res Public Health · 2022 · PMC9657653 · PMID 36361175

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

The renal function change (follow-up eGFR minus initial eGFR) showed a sharp decline in the treatment group compared to that in the control group, although this change did not reach statistical significance ( p = 0.07). 3.2.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.